Shares in gene-editing specialist Intellia Therapeutics came under renewed pressure today after a patient in one of its ...
Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback